✦ LIBER ✦

In vitro activity of fosfomycin against Haemophilus influenzae, Streptococcus pneumoniae and Neisseria species

✍ Scribed by K. Bartmann; R. Tarbuc

Publisher: Springer-Verlag
Year: 1980
Tongue: English
Weight: 539 KB
Volume: 8
Category: Article
ISSN: 0300-8126
DOI: 10.1007/bf01639037

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative activity of six beta-lactam

Comparative activity of six beta-lactam antibiotics against strains of haemophilus influenzae, neisseria meningitidis and streptococcus pneumoniae

✍ L. A. Soares; C. E. A. Melles 📂 Article 📅 1982 🏛 Springer-Verlag 🌐 English ⚖ 797 KB

In vitro activity of ceftazidime (GR 202

In vitro activity of ceftazidime (GR 20263) and other β-lactam antibiotics against Haemophilus influenzae

✍ P. Piot; E. Van Dyck; J. Colaert 📂 Article 📅 1983 🏛 Springer-Verlag 🌐 English ⚖ 725 KB

In vitro activity of second and third ge

In vitro activity of second and third generation cephalosporins against ampicillin susceptible and resistant haemophilus influenzae

✍ J. L. Burns; K. Wong; A. L. Smith 📂 Article 📅 1988 🏛 Springer-Verlag 🌐 English ⚖ 704 KB

In vitro activity of cefaclor against ha

In vitro activity of cefaclor against haemophilus influenzae in comparison to cephalexin, cephradine, cefadroxil, cefatrizine and ampicillin

✍ K. Bartmann; R. Tarbuc 📂 Article 📅 1981 🏛 Springer-Verlag 🌐 English ⚖ 782 KB

In vitro activity of tosufloxacin (A-609

In vitro activity of tosufloxacin (A-60969) and clarithromycin (A-56268, TE-031) against resistantHaemophilus influenzae, Streptococcus pneumoniaeandBranhamella catarrhalisisolates

✍ J. P. Bryan; C. Waters; J. Sheffield; K. F. Wagner 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 489 KB

Policy analysis of the use of hepatitis

Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules

✍ Mark A. Miller; Laura McCann 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

After the development of national vaccine programmes to deliver six vaccines to infants, new vaccine adoption has been limited. Analysis of the health and economic implications of new vaccination options can help national policy-makers. Country specific quantitative policy analyses were conducted t